These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31279579)

  • 1. A novel designer drug, 25N-NBOMe, exhibits abuse potential via the dopaminergic system in rodents.
    Seo JY; Hur KH; Ko YH; Kim K; Lee BR; Kim YJ; Kim SK; Kim SE; Lee YS; Kim HC; Lee SY; Jang CG
    Brain Res Bull; 2019 Oct; 152():19-26. PubMed ID: 31279579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential.
    Custodio RJP; Sayson LV; Botanas CJ; Abiero A; You KY; Kim M; Lee HJ; Yoo SY; Lee KW; Lee YS; Seo JW; Ryu IS; Kim HJ; Cheong JH
    Addict Biol; 2020 Nov; 25(6):e12850. PubMed ID: 31749223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel psychoactive substance 25E-NBOMe induces reward-related behaviors via dopamine D1 receptor signaling in male rodents.
    Kim YJ; Kook WA; Ma SX; Lee BR; Ko YH; Kim SK; Lee Y; Lee JG; Lee S; Kim KM; Lee SY; Jang CG
    Arch Pharm Res; 2024 Apr; 47(4):360-376. PubMed ID: 38551761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designer Drug, 25D-NBOMe, Has Reinforcing and Rewarding Effects through Change of a Dopaminergic Neurochemical System.
    Lee JG; Hur KH; Hwang SB; Lee S; Lee SY; Jang CG
    ACS Chem Neurosci; 2023 Aug; 14(15):2658-2666. PubMed ID: 37463338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT
    Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Johnson RA; Janowsky A
    Biochem Pharmacol; 2018 Dec; 158():27-34. PubMed ID: 30261175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two newly-emerging substituted phenethylamines MAL and BOD induce differential psychopharmacological effects in rodents.
    Custodio RJP; Sayson LV; Botanas CJ; Abiero A; Kim M; Lee HJ; Ryu HW; Lee YS; Kim HJ; Cheong JH
    J Psychopharmacol; 2020 Sep; 34(9):1056-1067. PubMed ID: 32648801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Abuse Potential of Novel Synthetic Phencyclidine Derivative 1-(1-(4-Fluorophenyl)Cyclohexyl)Piperidine (4'-F-PCP) in Rodents.
    Ryu IS; Kim OH; Lee YE; Kim JS; Li ZH; Kim TW; Lim RN; Lee YJ; Cheong JH; Kim HJ; Lee YS; Steffensen SC; Lee BH; Seo JW; Jang EY
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats.
    Herian M; Wojtas A; Kamińska K; Świt P; Wach A; Gołembiowska K
    Neurotox Res; 2019 Jul; 36(1):91-100. PubMed ID: 30989482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New designer phenethylamines 2C-C and 2C-P have abuse potential and induce neurotoxicity in rodents.
    Kim YJ; Ma SX; Hur KH; Lee Y; Ko YH; Lee BR; Kim SK; Sung SJ; Kim KM; Kim HC; Lee SY; Jang CG
    Arch Toxicol; 2021 Apr; 95(4):1413-1429. PubMed ID: 33515270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation.
    Oh JH; Hwang JY; Hong SI; Ma SX; Seo JY; Lee SY; Kim HC; Jang CG
    Addict Biol; 2018 Jan; 23(1):69-79. PubMed ID: 27790823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro phase I metabolism of three phenethylamines 25D-NBOMe, 25E-NBOMe and 25N-NBOMe using microsomal and microbial models.
    Grafinger KE; Stahl K; Wilke A; König S; Weinmann W
    Drug Test Anal; 2018 Oct; 10(10):1607-1626. PubMed ID: 29971945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profile determination of 25N-NBOMe in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry.
    Seo H; Kim IS; Kim YH; Yoo HH; Hong J
    Int J Legal Med; 2019 May; 133(3):833-841. PubMed ID: 30090972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new stimulant designer compound pentedrone exhibits rewarding properties and affects dopaminergic activity.
    Hwang JY; Kim JS; Oh JH; Hong SI; Ma SX; Jung YH; Ko YH; Lee SY; Kim HC; Jang CG
    Addict Biol; 2017 Jan; 22(1):117-128. PubMed ID: 26290055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review.
    Kamińska K; Świt P; Malek K
    J Anal Toxicol; 2021 Jan; 44(9):947-956. PubMed ID: 32128596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The abuse potential of two novel synthetic cathinones with modification on the alpha-carbon position, 2-cyclohexyl-2-(methylamino)-1-phenylethanone (MACHP) and 2-(methylamino)-1-phenyloctan-1-one (MAOP), and their effects on dopaminergic activity.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Woo T; Seo JW; Jang CG; Park KT; Lee YH; Lee YS; Kim HJ; Cheong JH
    Pharmacol Biochem Behav; 2017 Feb; 153():160-167. PubMed ID: 28063946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2017 Aug; 28(5):375-385. PubMed ID: 28537942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
    Wood DM; Sedefov R; Cunningham A; Dargan PI
    Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels.
    Abiero A; Botanas CJ; Custodio RJ; Sayson LV; Kim M; Lee HJ; Kim HJ; Lee KW; Jeong Y; Seo JW; Ryu IS; Lee YS; Cheong JH
    Psychopharmacology (Berl); 2020 Mar; 237(3):757-772. PubMed ID: 31828394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventral Tegmental Area Dopamine Cell Activation during Male Rat Sexual Behavior Regulates Neuroplasticity and d-Amphetamine Cross-Sensitization following Sex Abstinence.
    Beloate LN; Omrani A; Adan RA; Webb IC; Coolen LM
    J Neurosci; 2016 Sep; 36(38):9949-61. PubMed ID: 27656032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new synthetic drug 5-(2-aminopropyl)indole (5-IT) induces rewarding effects and increases dopamine D1 receptor and dopamine transporter mRNA levels.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Custodio RJ; Woo T; Seo JW; Jang CG; Yang JS; Yoon YM; Lee YS; Kim HJ; Cheong JH
    Behav Brain Res; 2018 Apr; 341():122-128. PubMed ID: 29288746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.